Herzich Paul 4
4 · Solid Biosciences Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Solid Biosciences CTO Paul Herzich Sells 10,905 Shares
What Happened Paul Herzich, Chief Technology Officer of Solid Biosciences (SLDB), reported a sale of 10,905 shares on 2026-02-04. The shares were sold for a weighted average price of $6.44 per share, generating proceeds of approximately $70,249. This was a sale (S) and not a purchase—specifically a sell-to-cover tied to the vesting of previously granted restricted stock units (RSUs).
Key Details
- Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (timely; within the usual 2-business-day window).
- Price: weighted average $6.44; individual trade prices ranged from $6.28 to $6.60.
- Shares sold: 10,905; proceeds ≈ $70,249.
- Reason: sale executed to cover withholding taxes on vested RSUs pursuant to a durable automatic sell-to-cover instruction adopted by Mr. Herzich on August 16, 2024 (per footnote).
- Disclosure: sale was not a discretionary trade by the insider (sell-to-cover instruction). The filer offers to provide breakdown of number of shares sold at each price within the reported range upon request.
- Shares owned after the transaction: not specified in the provided excerpt of the Form 4.
Context Sell-to-cover transactions occur when newly vested RSU shares are sold to satisfy tax withholding and are generally routine; they do not necessarily signal a change in an insider's view of the company. This filing reflects a tax-withholding sale rather than an open-market, discretionary divestiture.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-02-04$6.44/sh−10,905$70,249→ 69,067 total
Footnotes (2)
- [F1]This sale was made to cover withholding taxes following the vesting of previously granted restricted stock units pursuant to a durable automatic sale instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.28 to $6.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.